← back to search

Tom Fletcher

University of Liverpool · GB
Area of research
Infectious Diseases · Emergency Medical Services
Research interest
Research interests include Viral Infections and Outbreaks Research, COVID-19 Clinical Research Studies, SARS-CoV-2 and COVID-19 Research, and Viral Infections and Vectors.
h-index
42
citations
11,392
works
200
NIH funding
primary concept
Medicine
email

Recent publications

Prevalence of extended-spectrum β-lactamase-producing Enterobacterales and carbapenemase-resistant Enterobacterales in British military cohorts.
2026cited by 2position: contributordoi
Optimal Dose and Safety of Intravenous Favipiravir in Hospitalized Patients With <scp>COVID</scp> ‐19: A Dose‐Escalating, Randomized Controlled Phase Ib Study
Clinical Pharmacology & Therapeutics 2026cited by 1position: middledoi
Safe delivery of intensive care for Marburg virus disease in Rwanda.
2026cited by 1position: contributordoi
Diagnostics and the 100-day mission: why preparedness cannot wait.
2026cited by 0position: contributordoi
Epidemiology and impact of travellers' diarrhoea differs during UK military training exercises in Kenya and Oman.
2026cited by 0position: contributordoi
Development and evaluation of a novel RT-qPCR assay for detection of Crimean Congo haemorrhagic fever virus using the Genedrive® point-of-care platform.
2026cited by 0position: contributordoi
Illustrative case series of eosinophilia in UK Armed Forces personnel and recommended management for non-specialists.
2026cited by 0position: contributordoi
Optimal Dose and Safety of Intravenous Favipiravir in Hospitalized Patients With COVID-19: A Dose-Escalating, Randomized Controlled Phase Ib Study.
2026cited by 0position: contributordoi
Randomized multi-country adaptive phase IIb platform trial evaluating treatments for Crimean-Congo haemorrhagic fever (UMIT-2 Trial)
http://isrctn.com/ 2026cited by 0position: contributordoi
Research and product development for Crimean-Congo haemorrhagic fever: priorities for 2024-30.
2025cited by 13position: contributordoi
Diagnostic Accuracy of 3 Mpox Lateral Flow Assays for Antigen Detection, Democratic Republic of the Congo and United Kingdom.
2025cited by 5position: contributordoi
Marburg Virus Disease in Rwanda, 2024 - Public Health and Clinical Responses.
2025cited by 4position: contributordoi
Air and surface sampling for clade Ib monkeypox virus in United Kingdom hospitals, 2024 to 2025.
2025cited by 3position: contributordoi
Evaluation of the diagnostic accuracy of Xpert® Mpox and STANDARD™ M10 MPX/OPX for the detection of monkeypox virus.
2025cited by 3position: contributordoi
A Comparison of Clinical and Laboratory Features of Crimean-Congo Hemorrhagic Fever in Children and Adults: A Retrospective Single-Center Cohort Study and Literature Review.
2025cited by 2position: contributordoi
Embedding treatment in stronger care systems.
2025cited by 2position: contributordoi
Monkeypox virus isolation from longitudinal samples in 11 hospitalised patients.
2025cited by 2position: contributordoi
Arboviruses in UK Armed Forces: a review of historical cases and identification of future threats.
2025cited by 1position: contributordoi
Optimal dose and safety of intravenous favipiravir in hospitalised patients with SARS-CoV-2 infection: a Phase Ib, open-label, dose-escalating, randomised controlled study
medRxiv 2025cited by 0position: lastdoi
Persistence of SARS-CoV-2 Antibody Response across Diverse Clinical Settings in Oman: Insights from a Prospective ELISA-based Study.
2025cited by 0position: contributordoi
Routes of transmission of mpox by virus clade and geographic distribution: A systematic review.
2025cited by 0position: contributordoi
UK military infection referral service: a review of activity 2018-2024.
2025cited by 0position: contributordoi
Prospective evaluation of different faecal preservation media for travellers’ diarrhoea diagnostic application with multiplex PCR BioFire FilmArray in resource-limited settings
Journal of Medical Microbiology 2025cited by 0position: contributordoi
Optimal dose and safety of intravenous favipiravir in hospitalised patients with SARS-CoV-2 infection: a Phase Ib, open-label, dose-escalating, randomised controlled study
2025cited by 0position: contributordoi
A Multiplex qPCR to Differentiate Monkeypox Virus Clades
2025cited by 0position: contributordoi
Adaptive Design for Phase II/III Platform Trial of Lassa Fever Therapeutics.
2025cited by 0position: contributordoi
A randomised-controlled Phase I de-escalation trial of Molnupiravir and Nirmatrelvir/Ritonavir combination for mild-moderate SARS-CoV-2 infection
2025cited by 0position: contributordoi
Ebola disease outbreak caused by the Sudan virus in Uganda, 2022: a descriptive epidemiological study.
2024cited by 22position: contributordoi
Research and product development for Crimean–Congo haemorrhagic fever: priorities for 2024–30
The Lancet Infectious Diseases 2024cited by 16position: middledoi
Long Covid: a global health issue - a prospective, cohort study set in four continents.
2024cited by 13position: contributordoi

Grants

No grants ingested yet.

Frequent collaborators

Saye Khoo · University of Liverpool27 papers (2020–2025)Peter Horby · Johns Hopkins Hospital15 papers (2020–2025)Thomas Jaki · OTH Regensburg9 papers (2021–2025)David G. Lalloo · Liverpool School of Tropical Medicine9 papers (2019–2025)Lance CW Turtle · Johns Hopkins Hospital9 papers (2020–2022)Nicholas J. Beeching · Liverpool School of Tropical Medicine8 papers (2019–2026)Gareth Griffiths · Cancer Research UK8 papers (2021–2025) · 8 papers (2020–2026)J Kenneth Baillie · University of Southampton7 papers (2020–2025)Allan M Bennett · Public Health England7 papers (2022–2023) · 7 papers (2021–2025)Müge Çevik · University of St Andrews6 papers (2020–2023)Robert Fowler · Sunnybrook Health Science Centre6 papers (2020–2026)Vanessa Sancho-Shimizu · Johns Hopkins Hospital6 papers (2022–2025)Alexander J. Mentzer · Moscow Institute of Thermal Technology6 papers (2022–2025)Luis E Cuevas · Liverpool School of Tropical Medicine6 papers (2020–2022)Janet T Scott · Montreal Heart Institute5 papers (2020–2025)Christopher A Green · Johns Hopkins Hospital5 papers (2020–2023)Charlotte Summers · University of Sheffield5 papers (2022–2025)Srinivas Murthy · University of Bari Aldo Moro5 papers (2020–2024)